MeSH tree: C19.246.774
An elevated blood glucose level one hour after the oral glucose tolerance test (OGTT) signals a critical metabolic state—even before prediabetes. Affected individuals respond particularly well to lifestyle interventions. ...
Nov 12, 2025
0
18
More than half of calories consumed in the United States come from ultra-processed foods (UPFs), items like fast food and packaged snacks that are often high in sodium, sugar and unhealthy fats. In adults, research has clearly ...
Nov 11, 2025
0
19
Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes similarly to traditional, human-led ...
Oct 27, 2025
0
16
There's a long-held belief in diabetes prevention that weight loss is the main way to lower disease risk. Our new study challenges this.
Oct 4, 2025
0
138
It's estimated that nearly half of adults aged 65 and older are living with prediabetes, a condition that predisposes them to developing type 2 diabetes and puts them at higher risk for cardiovascular complications.
Oct 1, 2025
0
10
Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type 2 diabetes improve blood sugar control. In 2024, the U.S. Food and Drug Administration approved ...
Oct 1, 2025
0
19
Until now, weight reduction has been the primary therapeutic goal for people with prediabetes. An analysis of a large Tübingen study shows that patients who bring their blood sugar levels back within the normal range through ...
Sep 29, 2025
0
65
If presented with two snacks, one containing 7 grams of sugar and another with over 30 grams of sugar, choosing the healthier option should be a no-brainer, correct? Well, maybe not. Less sugar is not automatically healthier.
Sep 25, 2025
0
50
In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic, weight, and cardiometabolic outcomes, according to a study published in JAMA Pediatrics.
Sep 23, 2025
0
11
A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight reduction than placebo over 64 weeks in adults with overweight or obesity.
